Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 184

Sort by

Sort Order Select

Journal Articles

Disruption of DNA-PK-Mediated Cgas Retention on Damaged Chromatin Potentiates Doxorubicin-Induced Cgas/Sting-Dependent Anti-Multiple Myeloma Activity

Jinna Zhang, Mengmeng Dong, Anyong Xie, Zhen Cai

Blood (2023) 142 (Supplement 1): 3315.

https://doi.org/10.1182/blood-2023-177857

Published: 2023

Journal Articles

A Prospective Phase II Clinical Study of Low-Frequency Daratumumab for the Treatment of Systemic Light Chain Amyloidosis

Donghua He, Xinyi Meng, Jingsong He, Wenjun Wu, Jinuo Wang, Chunting Zhu, Xiaoyan Han, Yi Zhao, Gaofeng Zheng, Yi Li, Xing Guo, Qingxiao Chen, Fangshu Guan, Zhen Cai

Blood (2023) 142 (Supplement 1): 3400.

https://doi.org/10.1182/blood-2023-184689

Published: 2023

Journal Articles

PI3Kδ Inhibitor Linperlisib As a ≥ 3-Line Treatment for Relapsed or Refractory Follicular Lymphoma: A Subgroup Analysis of a Phase II, Single-Arm, Open-Label Trial

Blood (2023) 142 (Supplement 1): 1677.

https://doi.org/10.1182/blood-2023-178710

Published: 2023

Journal Articles

The Efficacy of Roxadustat in Multiple Myeloma Patients with Renal Insufficiency and Anemia: A Real-World Study

Shuchan Li, Xiaoyan Han, Gaofeng Zheng, Jingsong He, Wenjun Wu, Yang Yang, Qingxiao Chen, Donghua He, Mengmeng Dong, Jinuo Wang, Yi Li, Li Yang, Zhen Cai

Blood (2023) 142 (Supplement 1): 4726.

https://doi.org/10.1182/blood-2023-184617

Published: 2023

Journal Articles

Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm

Blood (2023) 142 (Supplement 1): 2228.

https://doi.org/10.1182/blood-2023-184668

Published: 2023

Journal Articles

Reduced Intensity Condition of ATG Based Haploidentical Hematopoietic Stem Cell Transplantation in Elderly or Unfit Patients

Mingyue Pan, Yibo Wu, Luxin Yang, Jimin Shi, Xiaoyu Lai, Lizhen Liu, Yanmin Zhao, Jian Yu, Sun Jie, Weiyan Zheng, Wenjun Wu, Zhen Cai, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 6977.

https://doi.org/10.1182/blood-2023-186211

Published: 2023

Journal Articles

The Ratio of Urea Nitrogen to Albumin Is a Better Predictor of OS in MM Patients Than That of Urea Nitrogen Alone

Mengmeng Dong, Jiaqi Shao, Enfan Zhang, Haoguang Chen, Zhen Cai, Tao Cheng

Blood (2023) 142 (Supplement 1): 6688.

https://doi.org/10.1182/blood-2023-184847

Published: 2023

Journal Articles

Cladribine Combined with Homoharringtonine and Cytarabine Achieves a High Remission Rate in Adult Patients with De Novo Acute Myeloid Leukemia, Especially for Adverse-Risk Group: A Prospective, Single Center, Single-Arm, Phase 2 Study

Yuanyuan Zhu, Weijia Huang, Jinya Lin, Zhen Cai, Xiujin Ye, Shanshan Pei, Ying Xie, Xiaoqing Zou, Shaoqi Zhang, He Huang, Jie Sun

Blood (2023) 142 (Supplement 1): 1524.

https://doi.org/10.1182/blood-2023-186579

Published: 2023

Journal Articles

Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Asian Patients with Newly Diagnosed Multiple Myeloma: Final Analysis of the Phase 3 Octans Study

Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, Chor Sang Chim, Robin Carson, Rui Liu, Lingling Wang, Man Zhao, Xi Chen, Canchan Cui, Jian Hou, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 3388.

https://doi.org/10.1182/blood-2023-181063

Published: 2023

Journal Articles

Biological and Therapeutic Implications of NPM1 -Mutated AML Receiving Allogeneic Hematopoietic Cell Transplantation

Xiaolin Yuan, Yibo Wu, Xiaoyu Lai, Luxin Yang, Jimin Shi, Lizhen Liu, Jian Yu, Yanmin Zhao, Weiyan Zheng, Wenjun Wu, Yi Zhao, Zhen Cai, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 7037.

https://doi.org/10.1182/blood-2023-189289

Published: 2023

Journal Articles

Comparison of Long-Term Outcome between Imatinib and Dasatinib Prophylaxis after Allogeneic Stem Cell Transplantation in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia-a Multi-Center Retrospective Study

Fangshu Guan, Luxin Yang, Panpan Zhu, Xiaoyu Lai, Lizhen Liu, Jimin Shi, Yanmin Zhao, Jian Yu, Huarui Fu, Yi Zhao, Jianping Lan, Yi Chen, Ying Lu, Guifang Ouyang, Yang Xu, Xi Qiu, Zhen Cai, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 7056.

https://doi.org/10.1182/blood-2023-184478

Published: 2023

Journal Articles

A Single Center Retrospective Study on the Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Myeloid Neoplasms over 50 Years Old

Meng Liu, Xiaoli Wang, Yi Luo, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin Shi

Blood (2023) 142 (Supplement 1): 7051.

https://doi.org/10.1182/blood-2023-184513

Published: 2023

Journal Articles

Pre-treatment 18 f-FDG PET/CT for Assessing and Predicting Bone Marrow Involvement in Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

Jing Chen, Zhen Cai, Yi Zhao

Blood (2023) 142 (Supplement 1): 4494.

https://doi.org/10.1182/blood-2023-185427

Published: 2023

Journal Articles

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma:Pathological Phenotype and Genetic Mutation Analysis of 12 Patients

Linlin Huang, Hanjin Yang, Yang Yang, Fang Yu, Yi Zhao, Xiujin Ye, Weiyan Zheng, Jie Sun, Enfan Zhang, Zhen Cai, Jingsong He

Blood (2023) 142 (Supplement 1): 4448.

https://doi.org/10.1182/blood-2023-186056

Published: 2023

Journal Articles

Real-World Clinical Outcomes of Pomalidomide-Based and Daratumumab-Based Therapies in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Center Retrospective Cohort Study

Xiaoyan Han, Xincheng Jiang, Jingsong He, Gaofeng Zheng, Yaqin Xiong, Yanling Wen, Yang Yang, Donghua He, Qingxiao Chen, Wenjun Wu, Yi Zhao, Yi Li, Zhen Cai

Blood (2023) 142 (Supplement 1): 6639.

https://doi.org/10.1182/blood-2023-184794

Published: 2023

Journal Articles

Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study

Blood (2023) 142 (Supplement 1): 6140.

https://doi.org/10.1182/blood-2023-180373

Published: 2023

Journal Articles

Hyperleukocytosis Does Not Present a Worse Prognosis in Acute Myeloid Leukemia (Non-APL) with Favorable Risk According to ELN-2022 Criteria: A Retrospective Study

Shuyue Bao, Jinya Lin, Yuanyuan Zhu, Weijia Huang, Weiyan Zheng, Guoqing Wei, Zhen Cai, Yi Luo, Yi Zhao, Jimin Shi, He Huang, Jie Sun

Blood (2023) 142 (Supplement 1): 5867.

https://doi.org/10.1182/blood-2023-186943

Published: 2023

Journal Articles

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Blood (2023) 142 (Supplement 1): 3579.

https://doi.org/10.1182/blood-2023-189068

Published: 2023

Journal Articles

Clinical Characteristics Analysis of Gastrointestinal Peripheral T-Cell Lymphoma:Impact of Non-Emergency Surgery on Overall Survival

Jingsong He, Linlin Huang, Yang Yang, Yi Zhao, Xiu-Jin Ye, Weiyan Zheng, Sun Jie, Zhen Cai

Blood (2023) 142 (Supplement 1): 6214.

https://doi.org/10.1182/blood-2023-185509

Published: 2023

Journal Articles

Phase I Clinical Study of Humanized BCMA-Single-Domain Antibodies-Targeting CAR T (BCMA-CART) in Patients with Relapsed/Refractory Multiple Myeloma

Gaofeng Zheng, Heng Mei, Gang Ye, Ling Zhou, Cheng Wen, Zhuoxiao Cao, Zhen Cai

Blood (2023) 142 (Supplement 1): 3489.

https://doi.org/10.1182/blood-2023-186619

Published: 2023

NARROW

Disruption of DNA-PK-Mediated Cgas Retention on Damaged Chromatin Potentiates Doxorubicin-Induced Cgas/Sting-Dependent Anti-Multiple Myeloma Activity

A Prospective Phase II Clinical Study of Low-Frequency Daratumumab for the Treatment of Systemic Light Chain Amyloidosis

PI3Kδ Inhibitor Linperlisib As a ≥ 3-Line Treatment for Relapsed or Refractory Follicular Lymphoma: A Subgroup Analysis of a Phase II, Single-Arm, Open-Label Trial

The Efficacy of Roxadustat in Multiple Myeloma Patients with Renal Insufficiency and Anemia: A Real-World Study

Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm

Reduced Intensity Condition of ATG Based Haploidentical Hematopoietic Stem Cell Transplantation in Elderly or Unfit Patients

The Ratio of Urea Nitrogen to Albumin Is a Better Predictor of OS in MM Patients Than That of Urea Nitrogen Alone

Cladribine Combined with Homoharringtonine and Cytarabine Achieves a High Remission Rate in Adult Patients with De Novo Acute Myeloid Leukemia, Especially for Adverse-Risk Group: A Prospective, Single Center, Single-Arm, Phase 2 Study

Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Asian Patients with Newly Diagnosed Multiple Myeloma: Final Analysis of the Phase 3 Octans Study

Biological and Therapeutic Implications of NPM1 -Mutated AML Receiving Allogeneic Hematopoietic Cell Transplantation

Comparison of Long-Term Outcome between Imatinib and Dasatinib Prophylaxis after Allogeneic Stem Cell Transplantation in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia-a Multi-Center Retrospective Study

A Single Center Retrospective Study on the Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Myeloid Neoplasms over 50 Years Old

Pre-treatment 18 f-FDG PET/CT for Assessing and Predicting Bone Marrow Involvement in Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma:Pathological Phenotype and Genetic Mutation Analysis of 12 Patients

Real-World Clinical Outcomes of Pomalidomide-Based and Daratumumab-Based Therapies in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Center Retrospective Cohort Study

Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study

Hyperleukocytosis Does Not Present a Worse Prognosis in Acute Myeloid Leukemia (Non-APL) with Favorable Risk According to ELN-2022 Criteria: A Retrospective Study

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Clinical Characteristics Analysis of Gastrointestinal Peripheral T-Cell Lymphoma:Impact of Non-Emergency Surgery on Overall Survival

Phase I Clinical Study of Humanized BCMA-Single-Domain Antibodies-Targeting CAR T (BCMA-CART) in Patients with Relapsed/Refractory Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only